Stockholm - Delayed Quote SEK

BioInvent International AB (publ) (BINV.ST)

31.00
+0.60
+(1.97%)
At close: 5:29:57 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
60,804
44,686
71,461
326,126
19,384
Operating Expense
565,126
515,934
442,018
376,598
297,549
Operating Income
-504,322
-471,248
-370,557
-50,472
-278,165
Net Non Operating Interest Income Expense
--
41,535
39,967
8,422
-253
Pretax Income
-467,920
-429,240
-330,100
-42,503
-278,444
Tax Provision
141
135
204
0
0
Net Income Common Stockholders
-468,061
-429,375
-330,304
-42,503
-278,444
Diluted NI Available to Com Stockholders
-468,061
-429,375
-330,304
-42,503
-278,444
Basic EPS
-7.12
-6.53
-5.02
-0.69
-5.14
Diluted EPS
-7.12
-6.53
-5.02
-0.69
-5.14
Basic Average Shares
65,763.46
65,804
65,767
61,521
54,161
Diluted Average Shares
65,763.46
65,804
65,767
61,521
54,161
Total Operating Income as Reported
-504,133
-471,059
-369,942
-50,921
-278,350
Total Expenses
565,126
515,934
442,018
376,598
297,549
Net Income from Continuing & Discontinued Operation
-468,061
-429,375
-330,304
-42,503
-278,444
Normalized Income
-464,697.40
-429,375
-330,304
-42,503
-278,444
Interest Income
--
42,090
40,605
9,072
264
Interest Expense
--
555
638
650
517
Net Interest Income
--
41,535
39,967
8,422
-253
EBIT
-461,759
-428,685
-329,462
-41,853
-277,927
EBITDA
-450,092
-417,443
-320,199
-27,129
-263,317
Reconciled Depreciation
11,667
11,242
9,263
14,724
14,610
Net Income from Continuing Operation Net Minority Interest
-468,061
-429,375
-330,304
-42,503
-278,444
Total Unusual Items Excluding Goodwill
-5,606
41,819
39,842
--
--
Total Unusual Items
-5,606
41,819
39,842
--
--
Normalized EBITDA
-444,486
-417,443
-320,199
-27,129
-263,317
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,242.40
0
0
0
0
12/31/2021 - 6/12/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACTI.ST Active Biotech AB (publ)
0.1178
+0.51%
 
IMMU.ST Mendus AB (publ)
5.20
-3.53%
 
VICO.ST Vicore Pharma Holding AB (publ)
8.19
+3.54%
 
XBRANE.ST Xbrane Biopharma AB (publ)
0.2640
-1.49%
 
SANION.ST Saniona AB (publ)
8.39
+0.24%
 
HNSA.ST Hansa Biopharma AB (publ)
24.20
-1.06%
 
BIOVIC-B.ST Biovica International AB (publ)
0.9680
-5.10%
 
ONCO.ST Oncopeptides AB (publ)
1.9520
-2.30%
 
SPAGO.ST Spago Nanomedical AB (publ)
0.1825
-0.27%
 
ALZ.ST Alzinova AB (publ)
1.7860
-0.11%